Home / Other / Cell Expansion - Global Market

Cell Expansion - Global Market

  • Id : RNR-53859
  • Category : Other
  • Publish Date : November 2016
  • Pages : 0
  • Publisher : Stratistics MRC
License Type

According to Stratistics MRC, the Global Cell expansion market is accounted for $7.23 billion in 2015 and is expected to reach $23.86 billion by 2022 growing at a CAGR of 18.59%. Increasing R&D investments by government as well as companies on new cell based products, rising occurrence of chronic diseases and advancements in technology are some of the factors driving the market. However, high costs of cell based research and inflexible government regulations are the factors restricting the market growth.

Human cells segment is expected to witness the highest share during the forecast period. The favourable growth is attributed to high R&D investments. North America accounted for the largest share in the market owing to R&D investments. Asia Pacific is expected to register the highest CAGR during the forecast period.

Some of the key players in global cell expansion market include Sigma Aldrich Corporation, Acea Bioscience, Inc., Thermo Fisher Scientific, Inc., Alere Inc., Danaher Corporation, 300Microns Gmbh, GE Healthcare, Becton, Dickinson and Company, Terumo BCT, Inc., Miltenyi Biotec, Merck KGAA, Corning, Inc., Stemcell Technologies, Axol Bioscience, Lonza Group Ltd., Beckman Coulter, Inc. , Abec Inc and Applikon Biotechnologies.      

Applications Covered:
•  Regenerative Medicine and Stem Cell Research
• Stem Cell Research
• Cancer and Cell-based Research
• Clinical Diagnostics

Products Covered:
• Consumables
o Disposables
§ Bioreactor accessories
§ Tissue culture flasks
§ Other disposables
o Reagents, Media, and Serum
• Instruments
o Bioreactors
§  Microcarrier Bioreactor
§ Suspension-based for anchorage independent
§ Microcarrier-based for Anchorage dependent
§ Single Use/Disposable Bioreactors
§ Stirred Type Bioreactors
§ Bubble Column And Airlift Bioreactors
o Cell Expansion Supporting Equipment
§ Centrifuges
§ Flow cytometers
§ Cell counters
§ Other supporting equipment

End Users Covered:
• Biopharmaceutical and Biotechnology Companies
• Cell Banks
• Research Institutes
o  Hospitals and Biobanks
o Academic Research Institutes
• Other End Users

Cell Types Covered:
• Animal cells
• Human cells
o Stem cells
§ Adult stem cells
o Neural Stem Cells (NSCs)
o Mesenchymal Stem Cells (MSC)
o Hematopoietic Stem Cells (HSCs)
• Embryonic stem cells
• Differentiated cells
• Induced pluripotent stem cells

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements